Global Pharma Selects Kneat to Digitize Computer System Validation
October 08, 2024 17:04 ET
|
kneat.com, inc.
Another global pharmaceutical company selects Kneat to digitize its validation processes.
Anti-Infective Drugs Market Size Will Grow at a CAGR of 4.0% by 2031 | Surging Demand for Antivirals are Boost Market Development - Transparency Market Research, Inc.
October 08, 2024 08:36 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 08, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global anti-infective...
Antibody Production Market Expected to Reach USD 30.7 Billion by 2031, Growing at a CAGR of 7.8% from 2023 to 2031: Transparency Market Research, Inc.
October 08, 2024 07:35 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 08, 2024 (GLOBE NEWSWIRE) -- As per the report published by Transparency Market Research, the global antibody...
Avextra Announces the Approval of NEUROBIS by the Italian Medicines Agency: A Phase II Clinical Trial Using a Proprietary Cannabis-based Medicine for the Treatment of the Symptoms of Neurodegenerative Diseases
October 08, 2024 07:00 ET
|
Avextra AG
The Italian Medicines Agency AIFA and the Italian Ministry of Health have granted formal approval for NEUROBIS; a multi-centre Phase II study to evaluate safety, and efficacy of an Avextra oral...
Revolution Medicines to Deliver Multiple Presentations at the 2024 AACR-NCI-EORTC Symposium and Host Investor Webcast
October 07, 2024 09:00 ET
|
Revolution Medicines, Inc.
REDWOOD CITY, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted...
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update
October 04, 2024 07:30 ET
|
Lifecore Biomedical, Inc.
-- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 -- -- Signed Multiple New Business Agreements with New and Existing Customers -- -- More than Doubled Capacity with Installation of 5-Head...
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock
October 04, 2024 07:20 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing...
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024
October 03, 2024 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
ProductLife Group (PLG) Acquires Nextep to Further Expand its Global Patient Access Capabilities
October 03, 2024 03:00 ET
|
Groupe Product Life
ProductLife Group (PLG is pleased to announce the acquisition of Nextep, a reputed French consultancy specialized in market access and public affairs.
Exciting Advances in Ulcerative Colitis Treatments: Skyrizi Gains Early Momentum Following FDA Approval in June
October 01, 2024 10:51 ET
|
Spherix Global Insights
EXTON, PA, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The past twelve months have been transformative for the rapidly evolving ulcerative colitis (UC) market, with a surge in advanced therapies receiving FDA...